α-Conotoxin EI is a selective antagonist of neuromuscular nicotinic receptors α1β1γδ.
α-Conotoxin EI is a peptide neurotoxin derived from the venom of the marine cone snail Conus ermineus. As a member of the α-conotoxin family, it consists of a short amino acid sequence stabilized by disulfide bridges, conferring high specificity and affinity for certain neuronal nicotinic acetylcholine receptors (nAChRs). Its unique structural and pharmacological properties have made it an invaluable tool for dissecting the functional diversity of nAChR subtypes, as well as for advancing the understanding of synaptic transmission and neurochemical signaling. Researchers value α-Conotoxin EI for its ability to selectively modulate ion channel activity, enabling precise interrogation of neuronal pathways and receptor pharmacology.
Neuropharmacology research: One of the principal applications of α-Conotoxin EI lies in neuropharmacological studies aimed at elucidating the roles of nAChRs in the central and peripheral nervous systems. By selectively inhibiting specific nAChR subtypes, this peptide enables researchers to differentiate between receptor populations and to characterize their contributions to synaptic transmission, neuronal excitability, and neurotransmitter release. Such investigations are critical for understanding the molecular underpinnings of neural communication and for identifying potential targets for future pharmacological intervention.
Ion channel selectivity profiling: α-Conotoxin EI is frequently employed to assess the selectivity and functional properties of neuronal ion channels, particularly those formed by nAChR subunits. Its high binding affinity and subtype specificity allow for detailed mapping of receptor-ligand interactions, supporting the development of structure-activity relationship models. Through these studies, the peptide aids in the identification of key amino acid residues involved in ligand recognition and channel gating, providing insights that are essential for the rational design of novel channel modulators.
Peptide structure-function analysis: The well-defined disulfide-bonded framework of α-Conotoxin EI makes it an exemplary model for structure-function relationship studies within the conotoxin family. Researchers use it to investigate how specific sequence motifs and conformational features contribute to receptor binding and biological activity. Such analyses inform the broader field of peptide engineering, guiding the development of synthetic analogs with tailored pharmacological profiles and enhanced stability.
Analytical assay development: In laboratory settings, α-Conotoxin EI serves as a reference ligand or probe for developing and validating biochemical assays targeting nAChRs. Its robust and reproducible activity profile enables the establishment of high-throughput screening platforms for the evaluation of novel nAChR modulators. By incorporating this peptide into assay protocols, scientists can achieve greater specificity and sensitivity in detecting receptor-ligand interactions, thus streamlining the drug discovery process for neuroactive compounds.
Venom peptide research and evolutionary studies: Beyond its direct applications in neurobiology, α-Conotoxin EI contributes to the broader understanding of venom peptide diversity and evolution. Comparative analyses involving this conotoxin and related peptides shed light on the molecular strategies employed by cone snails to target prey and predators. Such research not only enhances knowledge of evolutionary adaptation and toxinology but also uncovers new scaffolds and mechanisms that may inspire future biotechnological innovation.
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More